300633.SZ
开立医疗
SZSE · Healthcare · C 制造业 · CN
CNY 19.11
−7.64%Year over year
Reported trailing growth
- Revenue
- +20.1%
- EBITDA
- —
- EBIT
- +678.7%
- EPS
- +253.9%
- Free cash flow
- +71.5%
- Operating cash flow
- +92.7%
Forward estimates
Based on analyst estimates
- Revenue
- +18.8%
- EBITDA
- +101.9%
- EPS
- +67.6%
Three-year CAGR
- Revenue
- +9.4%
- EBITDA
- -15.2%
- EBIT
- -24.4%
- Net income
- -18.9%
- EPS
- -18.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026